Cargando…
M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment
Atherosclerosis is a chronic progressive inflammation course, which could induce life-threatening diseases such as stroke and myocardial infarction. Optimal medical treatments for atherosclerotic risk factors with current antihypertensive and lipid-lowering drugs (for example, statins) are widely us...
Autores principales: | Bi, Ying, Chen, Jixiang, Hu, Feng, Liu, Jing, Li, Man, Zhao, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409015/ https://www.ncbi.nlm.nih.gov/pubmed/30923552 http://dx.doi.org/10.1155/2019/6724903 |
Ejemplares similares
-
Zebrafish Model for Screening Antiatherosclerosis Drugs
por: Han, Jichun, et al.
Publicado: (2021) -
Experimental Study of Antiatherosclerosis Effects with Hederagenin in Rats
por: Lu, Su-Hong, et al.
Publicado: (2015) -
Antiatherosclerosis Properties of Total Saponins of Garlic in Rats
por: Miao, Qing, et al.
Publicado: (2020) -
Simultaneous quantification and antiatherosclerosis effect of the traditional Korean medicine, Hwangryunhaedok-tang
por: Seo, Chang-Seob, et al.
Publicado: (2015) -
Potential Medications or Compounds Acting on Toll-like Receptors in Cerebral Ischemia
por: Li, Man, et al.
Publicado: (2018)